Health TrialsbyHealthPanel

Pediatric Relapsed

2

Review clinical trials related to Pediatric Relapsed. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias

To find the highest safe dose of ziftomenib that can be combined with venetoclax and azacitidine in pediatric participants with acute leukemia that has certain types of genetic mutations (changes).

Participants needed: 22
Trial details
Phase: Phase 1Age: 2-21Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Sep 3, 2026Locations: 1
Eligibility criteria

Age ≥ 2 year to 21 years [+8]

Participants who weigh less than 10kg. [+14]

Read more
Status: Recruiting

Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors

To collect information about treatment outcomes in pediatric and adolescent patients with relapsed/refractory germ cells tumors who receive GemDMC with an ASCT.

Participants needed: 30
Trial details
Age: 21+Biological sex: AllType: ObservationalSponsor: M.D. Anderson Cancer CenterUpdated: Jun 23, 2026Locations: 1
Eligibility criteria

Male or female participants, greater than 1 month of age up to 21 years old. Neo... [+2]

Participants who do not or did not receive GemDMC as part of the conditioning re...

Read more